F Prime Capital Partners Life Sciences Fund Vii Lp investment portfolio

AviadoBio creates gene‑therapy medicines and delivery technologies that target neurodegenerative disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, Alzheimer’s disease, tauopathies and retinal conditions. Its platform combines next‑generation gene‑therapy design with neuroscience expertise and a neuroanatomy‑led approach to deliver treatments to the brain and eye.

Peptone Ltd develops an AI‑driven operating system that automates protein drug engineering, providing a platform for fully automated design and production of therapeutic proteins. Its services target pharmaceutical and biotech companies seeking accelerated protein‑based drug discovery.